Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation by Nieminen, Mikko T. et al.
Treponema denticola chymotrypsin-like
proteinase may contribute to orodigestive
carcinogenesis through immunomodulation
Mikko T Nieminen*,1,12, Dyah Listyarifah2,3,12, Jaana Hagström4,5, Caj Haglund5,6, Daniel Grenier7,
Dan Nordström8, Veli-Jukka Uitto1, Marcela Hernandez9,10, Tülay Yucel-Lindberg11, Taina Tervahartiala1,
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Background: Periodontal pathogens have been linked to oral and gastrointestinal (orodigestive) carcinogenesis. However, the
exact mechanisms remain unknown. Treponema denticola (Td) is associated with severe periodontitis, a chronic inflammatory
disease leading to tooth loss. The anaerobic spirochete Td is an invasive bacteria due to its major virulence factor chymotrypsin-
like proteinase. Here we aimed to investigate the presence of Td chymotrypsin-like proteinase (Td-CTLP) in major orodigestive
tumours and to elucidate potential mechanisms for Td to contribute to carcinogenesis.
Methods: The presence of Td-CTLP within orodigestive tumour tissues was examined using immunohistochemistry. Oral, tonsillar,
and oesophageal squamous cell carcinomas, alongside gastric, pancreatic, and colon adenocarcinomas were stained with a
Td-CTLP-specific antibody. Gingival tissue from periodontitis patients served as positive controls. SDS–PAGE and immunoblot
were used to analyse the immumodulatory activity of Td-CTLP in vitro.
Results: Td-CTLP was present in majority of orodigestive tumour samples. Td-CTLP was found to convert pro MMP-8 and -9 into
their active forms. In addition, Td-CTLP was able to degrade the proteinase inhibitors TIMP-1, TIMP-2, and a-1-antichymotrypsin,
as well as complement C1q.
Conclusions: Because of its presence within tumours and regulatory activity on proteins critical for the regulation of tumour
microenvironment and inflammation, the Td-CTLP may contribute to orodigestive carcinogenesis.
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Over the past few decades, a paradigm shift has been made in
understanding the key role of the microbiome in health and
disease. Discovery of the causative role of Helicobacter pylori in
gastric cancer has been one of the driving factors in this area. It has
been estimated that 20% of all cancers have a microbial aetiology
(Parkin, 2006). Accumulating evidence has shown that microbes
have a more potent role in gastrointestinal (GI) carcinogenesis
than previously thought. Various members of the oral microbiota
have been reported to be linked to cancers of the GI tract
(Fitzpatrick & Katz, 2010; Ahn et al, 2012a, b).
In the oral microbiome, the so-called periodontopathogens,
including Fusobacterium nucleatum (Fn), Porphyromonas gingiva-
lis (Pg), Treponema denticola (Td), Aggregatibacter actinomyce-
temcomitans (Aa), and Tannerella forsythia (Tf) have been
receiving increasing interest in the context of cancer aetiology.
Periodontal microbes have a major role in the pathogenesis of
periodontitis, chronic inflammatory disease that causes destruction
of the tooth-supporting tissue and ultimately tooth loss. Novel
epidemiological studies have linked periodontal pathogens to
pancreatic and oral cancers (Ahn et al, 2012a; Michaud, 2013).
Also, it has been reported that Fn can promote colorectal
carcinogenesis (Rubinstein et al, 2013). Both in vitro and in vivo
studies have suggested that Fn and Pg participate in oral
carcinogenesis (Groeger et al, 2011; Gallimidi et al, 2015). Oral
bacteria may contribute to carcinogenesis via different mechanisms
such as inhibition of apoptosis, activation of cell proliferation,
promotion of cellular invasion, induction of chronic inflammation,
and production of carcinogens (Gallimidi et al, 2015). Bacterial
pathogens have developed various mechanisms that can promote
their ability to colonise the GI tract: strong adhesive properties;
immune evasion; disruption of epithelial integrity; and intracellular
survival (Ribet & Cossart, 2015).
Within the oral microbiome, Td is the most well-characterised
and frequently isolated spirochete (Dashper et al, 2011). In
addition to its association with periodontal disease, Td has been
reported to contribute to the formation of dental abscesses and
root canal infections. It is a highly invasive and motile organism,
and an obligate anaerobe. One of the key virulence factors of Td is
a cell surface-bound chymotrypsin-like proteinase (CTLP), also
known as dentilisin, which has a plethora of functions. It can
degrade multiple host proteins, hydrolyse bioactive peptides,
contribute to Td penetration into the epithelium, and enhance
integration of Td into biofilm communities (Grenier et al, 1990). In
addition, Td-CTLP can modulate immunity and inflammation,
and drive apoptosis in various cell types (Uitto et al, 1995; Cogoni
et al, 2012; Fenno, 2012). However, results reporting the
association of Td with malignancies are very limited and only
one study has reported the presence of Td in oesophageal tumours
(Narikiyo et al, 2004).
Host-derived matrix metalloproteinases (MMPs) have a critical
role in inflammatory processes and are capable of degrading almost
all extracellular proteins. MMPs are secreted by inflammatory cells,
in concert with endothelial, epithelial, and smooth muscle cells.
They facilitate leukocyte navigation through the extracellular
matrix (ECM) and modify immune responses by processing
non-matrix bioactive substrates (Salminen et al, 2015). The key
regulators of MMP activity are tissue inhibitors of MMPs (TIMPs).
There is a broad evidence highlighting the importance of MMPs
and TIMPs in the regulation of tumour microenvironment and in
the metastasis of GI cancers (Jiang et al, 2002; Verma et al, 2014).
In addition, other protease inhibitors are linked to carcinogen-
esis. Alpha-1-antichymotrypsin (a-1-AC) is an acute-phase protein
belonging to the serpin superfamily of protease inhibitors with
activity against various proteases such as neutrophil elastase and
cathepsin G. It has critical functions in tissue homeostasis and its
deficiency leads to chronic inflammation, which is associated with
several types of cancer, including gastric and colorectal cancers
(Kittas et al, 1982; Karashima et al, 1990; Sun & Yang, 2004). The
complement system has been known as the pivotal arm of the
innate immunity. In addition, being able to activate of the classical
pathway, complement C1q is known to be expressed in several
cancer tissues, including colorectal and pancreatic cancers (Bulla
et al, 2016).
In this study, we examined the presence of Td-CTLP in major
oral and GI (orodigestive) tumours in vivo using immunohisto-
chemistry. In addition, we also investigated the ability of Td-CTLP
to modulate immunomodulatory proteins, including MMPs,
TIMPs, a-1-AC, and C1q in vitro. The association of Td-CTLP
with orodigestive tumours has not been studied previously. We
hypothesised that CTLP is present in GI tract tumour tissue and
that it contributes to tumour progression is due its activity against
various immunomodulatory proteins critical for the regulation of
tumour microenvironment and inflammation.
MATERIALS AND METHODS
In vivo evaluation of the presence of Td-CTLP in cancer tissues
Antibody preparation. The CTLP antibody was prepared accord-
ingly (Grenier et al, 1990). The animal experiments were approved
by the experimentation ethics committee of Université Laval
(license no. 94-190). Briefly, the purified CTLP (15 mg) was injected
intramuscularly into a New Zealand White rabbit with complete
Freund adjuvant. Subsequent intramuscular injections, without
adjuvant, were done on days 8, 14, 22, 36, and 50. The rabbit was
bled via the marginal ear vein on day 57. The purified
immunoglobulin G (IgG) fraction was prepared by passing the
antiserum through a column of protein A-Sepharose CL 4B (Sigma
Chemical Co., St Louis, MO, USA). The sample was exhaustively
washed on the column with 0.1 M borate–0.5 M NaCl buffer (pH
8.4). Immunoglobulin G was then eluted with 0.1 M glycine–0.5 M
NaCl buffer (pH 2.5), followed by dialysis against 50 mM
phosphate-buffered saline (pH 7.2). The anti-CTLP IgG fraction
did not react with Treponema vincentii, an oral spirochete closely
related to Td, in immunofluorescence and ELISA assays indicating
high specificity of the antibody.
Immunohistochemical analysis. A total of 149 orodigestive
tumour tissue samples were obtained from the archives of
Department of Pathology, Helsinki University Hospital. The study
design complied with the Declaration of Helsinki and was
approved by the Ethical Committee of Helsinki University
Hospital. Tissue samples comprised squamous cell carcinomas
(SCCs) of tongue (n¼ 29), tonsil (n¼ 25), oesophagus (n¼ 3), and
adenocarcinoma of stomach (n¼ 32), pancreas (n¼ 6), and colon
(n¼ 54). All samples were formalin-fixed and paraffin-embedded.
Gingival tissue sample from patients with periodontitis verified
positive for Td by PCR were included as positive control (Marttila
et al, 2014). Mammae ductal carcinoma (n¼ 1), SCC of the lung
(n¼ 1), and various types of thyroid tumour tissues (n¼ 28) were
used for comparison as non-orodigestive tumour tissues.
Tissue sections were prepared according to standard protocol
(Marttila et al, 2014). Antigens were retrieved in citrate buffer
using microwaves (MicroMED T T Mega Histoprocessing Labsta-
tion; Milestone Srl, Sorisole, Italy). Immunohistochemical stainings
were performed using primary rabbit polyclonal antibody (1:1500
dilution) against Td-CTLP. The tissue sections were then incubated
with 1:200 dilution of corresponding biotinylated anti-rabbit
secondary antibody from the kit (Vectastain Elite ABC kit; Vector
Laboratories, Burlingame, CA, USA) and further incubated with
avidin–biotin–peroxidase complex. 3-amino-9-ethylcarbazole with
0.03% hydrogen peroxidase was used to reveal peroxidase-binding
site and counterstained with Mayer’s haematoxylin. Negative
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control stainings were performed with non-immune species-
specific Rabbit IgG (Vector Laboratories, Burlingame, CA, USA)
and by omitting the primary antibody. The samples were examined
and images were taken with Leica DM6000 light microscope
connected to a digital camera (DFC420 and DFC365FX; Leica
Microsystems, Wetzlar, Germany).
In vitro analysis of Td-CTLP activity
Purification of Td-CTLP and proMMPs. The purification of Td-
CTLP was done as previously described (Uitto et al, 1988; Grenier
et al, 1990). The CTLP was isolated from a sonicated cell extract of
Td 35405. The purity of the protease was verified by silver staining
and proteolytic activity detection on SDS–PAGE, which showed
only a single band with an apparent molecular mass of 95 kDa. The
protease showed a high specificity for the synthetic chromogenic
peptide succinyl-L-alanyl-L-alanyl-L-prolyl-L-phenylalanine-p-nitroa-
nilide, was activated by reducing agents, and was inhibited by
phenylmethylsulfonyl fluoride and sulfhydryl group reagents,
which was consistent with the characteristics previously.
The purification of proMMP-8 and proMMP-9 was done as
previously described (Sorsa et al, 1992, 1997). Briefly, supernatant
from stimulated human neutrophils was subjected to gel filtration
ion-exchange chromatography followed by affinity chromatogra-
phy on heat-denatured type I collagen (gelatin) coupled to
Sepharose for proMMP-9 and Cibacron-Blue Sepharose for
proMMP-8. The purified proMMP-8 and proMMP-9 were latent
and displayed no enzymatic activities.
Degradation of immunomodulatory components by Td-CTLP.
Native soluble type I and type II collagen (for MMP-8 and Td-
CTLP) as well as gelatin-zymography (for MMP-9 and Td-CTLP)
degradation assays were performed as previously described (Sorsa
et al, 1992, 1997). Native soluble 1.5 mM type I and II collagens were
purified and characterised by CNBr-cleavage analysis as previously
described (Sorsa et al, 1988). A unit of 400 ng of 75 kDa proMMP-
8, 400 ng of 92 kDa proMMP-9, 400 ng of 28 kDa human
recombinant TIMP-1 (R&D System, Oxon, UK), 400 ng of
21 kDa human recombinant TIMP-2 (R&D System), 400 ng a1-
AC (Sigma-Aldrich, St Louis, MO, USA), and 400 ng C1q (Abcam,
Cambridge, UK) were incubated with 80 ng of purified Td-CTLP
for various time periods extending from 0 to 60 min at 37 1C. As
positive control, proMMP-8 and -9 were also incubated for 60 min
(37 1C) with 1 mM organomercurial activator aminophenylmercu-
ric acetate (APMA; Sigma-Aldrich) and 25 ng human tumour-
associated trypsin-2. Human tumour-associated trypsin-2 was
purified from serum-free conditioned medium of COLO-205
human colon adenocarcinoma cells (American Type Culture
Collection, CCL-222, Rockville, MD, USA) (Sorsa et al, 1997).
After the incubations, the samples were removed, boiled for 5 min
in Laemmli’s sample buffer and run on SDS–PAGE (Coomassie
Brilliant Blue staining) and western immunoblotted to analyse the
conversions and fragmentations. Gelatin-zymography and sample
preparations for it were performed as described previously (Sorsa
et al, 1997).
RESULTS
Localisation of Td-CTLP in orodigestive cancer tissues
in vivo. To study the presence of Td-CTLP in malignant tumours,
various cancer specimens were stained by immunohistochemistry.
Td-CTLP was detected in all types of orodigestive cancer tissues,
including SCCs of tongue, tonsil, and oesophagus (Figure 1A–C).
The treponemal proteinase was also detected in adenocarcinomas
of the stomach, pancreas, and colon (Figure 1D–F). However, it
was not detected in every sample as described by the number of
positive samples in Figure 1. Immunoreactivity for Td-CTLP was
mainly detected in granular deposits in epithelial cell cytoplasm
within tumours. In addition, it was detected in some normal
tonsillar epithelial cells. Some mucus secretory cells such as goblet
cells, acinar cells, and ductal cells contained Td-CTLP as well.
Mononuclear inflammatory cells also showed weak positivity in
some specimens of all cancer types (data not shown).
As expected, the staining results on Td-positive gingival tissue
affected by periodontitis showed positivity for Td-CTLP and
negativity in non-orodigestive tumours, including breast and lung
cancer tissue (data not shown). For thyroid, limit and weak
expression was found in one follicular thyroid adenoma and one
follicular thyroid carcinoma, but negative in the rest, including
papillary thyroid carcinoma, medullary thyroid carcinoma, and
hyperplastic thyroid tissue (data not shown). Negative controls,
including stainings with IgG antibody and without primary
antibody showed no positivity (data not shown).
Activity of Td-CTLP in vitro. To elucidate mechanisms in which
way the Td-CTLP may affect tumour growth, some key proteins
connected to the regulation of the proteinase activities of the
tumours were incubated in the presence of the Td-CTLP (Figures
2–4). Treponema denticola-CTLP converted time-dependently the
75 kDa proMMP-8 to 60 kDa active forms of MMP-8 within
20–60 min as revealed by SDS–PAGE analysis (Figure 2A). The
conversion of 92 kDa proMMP-9 to 80–82 kDa active form of
MMP-9 by Td-CTLP also occurred in 20–60 min (Figure 2B).
Corresponding conversions of proMMP-8 and -9 to their active
counterparts were also obtained by 1 mM APMA and human
tumour-associated trypsin-2, used as positive controls (lane 2 in
Figure 2A and B, respectively). Furthermore, Td-CTLP fragmented
28 kDa TIMP-1 and 21 kDa TIMP-2 to small peptides and lower-
molecular-weight fragment as analysed by SDS–PAGE (Figure 2C
and D, respectively). The proMMP conversions analysed by SDS–
PAGE were further confirmed by western immunoblotting (Figure
3A and B). Treponema denticola-CTLP also efficiently fragmented
65 kDa a-1-AC (Figure 4A) and 68 kDa C1q (Figure 4B) to smaller
peptides.
Td-CTLP did not degrade native type I and II collagens
(Figure 5A, lanes 4 and 8, respectively). MMP-8 alone degraded to
some extent type I and II collagens (Figure 5A, lanes 3 and 6,
respectively). MMP-8 treated by Td-CTLP for 60 min prior
incubation with type I and II collagen resulted to significantly
enhanced degradation of both these collagens, preferably type II
collagen (Figure 5A, lanes 3 and 7, respectively). Type I gelatin-
zymographic analysis revealed that Td-CTLP is a gelatinolytic 80–
95 kDa protease (Figure 5B, lane 1) and time-dependently
converted gelatinolytic 92 kDa pro MMP-9 (Figure 5B, lane 2) to
active 82 kDa form (Figure 5B, lanes 3–5, indicated by an arrow).
DISCUSSION
In this study, we showed for the first time that the CTLP, a key
virulence factor specific to the oral spirochete Treponema denticola
(Td), is present in several orodigestive tumours. In addition, our
in vitro experiments provide evidence that Td-CTLP shows
immunomodulatory activity that can have a crucial role in
promoting and regulating carcinogenesis. Td is known to be a
key pathogen in periodontitis, a chronic inflammatory disease of
the tooth supporting connective tissue caused by the dysbiotic
microbiome. Previous studies regarding Td-CTLP have focused on
its potential role in the pathogenesis of periodontitis. However, the
role of the treponemal proteinase in carcinogenesis has not been
considered before. Recent studies have suggested a link between
periodontitis and oral cancer (Gholizadeh et al, 2016). The current
knowledge on the role of Td in chronic inflammation, and its
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highly invasive and immunomodulatory nature via its powerful
proteolytic machinery, urged us to investigate whether this
spirochete with the aid of its proteolytic enzyme has a part in
the aetiology of cancer.
Currently, there is very limited data available about the presence
of Td in malignant tumours. Narikiyo et al, using culture
independent-methods, reported frequent presence of Td together
with oral streptococci within oesophageal tumours obtained from
several centres globally. Td was more frequently isolated from
tumour than non-tumour sites. In our study, Td-CTLP was also
present in oesophageal tumour samples, and interestingly in the
majority of other orodigestive tumours as well.
Td can be isolated from the oral cavity of healthy individuals,
but in disease, the number of Td has been shown to increase
substantially alongside other periodontal pathogens (Dashper et al,
2011). The presence of Td-CTLP within orodigestive tumours
implicates that mucosal exposure along the GI tract to Td is due to
ingestion of the spirochete with food and saliva. In our study, this
implication is partly contradicted by the discovery of Td-CTLP in
pancreatic cancer. This can be explained by the fact that the
pancreas is connected to the bowel by its duct. It is also possible
that bacteria reach the pancreas via blood circulation. To
accompany the latter, Td has been detected in carotid and aortic
atheromatous plaques in patients with chronic periodontitis
(Cavrini et al, 2005).
We have previously investigated the localisation of Td and its
CTLP in oral gingival tissues affected by periodontitis (Marttila
et al, 2014). The localisation of Td-CTLP correlated well with the
presence of Td bacteria, and the CTLP was detected in all layers
from mucosal biofilm all the way through the epithelium to the
connective tissue, thus indicating the invasiveness of this organism.
Similar to our previous study, Td-CTLP was mainly localised
intracellularly within tumour cells in the current study. Td-CTLP is
known to facilitate binding of the spirochete to other bacterial
counterparts in polymicrobial biofilms and Td has been found to
coincide in the tissues with Pg, a periodontal pathogen that has
been associated with various types of orodigestive malignancies
such as colorectal, pancreatic, and oral cancers (Nagy et al, 1998;
Ahn et al, 2012a; Michaud et al, 2013).
In cancer progression and proliferation proteolytic activity is a
crucial factor, mainly carried out by MMPs. In vitro, Td-CTLP
converted proMMP-8 and -9 to their active forms as demonstrated
by western blots and type I and II collagen and gelatin-
zymographic MMP-activity assays. In fact, the Td-CTLP-activated
MMP-8 degraded preferentially native soluble type II collagen
relative to type I collagen, which is according to recorded substrate
specificity of MMP-8 (Hasty et al, 1987; Sorsa et al, 1988). The
MMPs regulate tumour cell tissue invasion and extravasation,
angiogenesis and inflammation, and thus have a major impact on
tumour microenvironment (Kessenbrock et al, 2010). Elevated
levels of MMP-9 have been associated with poor prognosis and
metastasis in tongue, oesophageal, gastric, pancreatic, and color-
ectal cancers (Zeng et al, 2013; Aparna et al, 2015; Jakubowska
et al, 2016). In periodontitis, the presence of Td is associated with
increased levels of MMP-8 and -9 (Yakob et al, 2013). Td is known
to trigger MMP-8 and -9 expression and secretion by inflammatory
cells in vitro (Ding et al, 1996; Choi et al, 2003). Interestingly, there
has been controversy over the effect of MMP-8 in cancer. Matrix
metalloproteinase-8 is overexpressed in oropharyngeal cancers and
moreover its expression is associated with poor prognosis in
ovarian and bladder cancer (Moilanen et al, 2002; Stadlmann et al,
2003; Kader et al, 2006). In addition, MMP-8 overexpression also
exhibits tumour- and metastasis-suppressing roles and associates
with improved survival in tongue and breast cancers (Gutierrez-
Fernandez et al, 2008; Korpi et al, 2008). In addition to ECM
modulation, MMP-8 and -9 show potent immunomodulatory
activity in tumour tissues (Kessenbrock et al, 2010).
Tissue inhibitors of MMPs act on tumour status primarily
through inhibition of MMPs. In addition, MMP-independent
effects of TIMPs on cell growth and differentiation, cell migration,
anti-angiogenesis, anti- and pro-apoptosis, and synaptic plasticity
have been reported (Brew & Nagase, 2010). TIMP-1 and -2 are
widely expressed (Jackson et al, 2016). TIMP-1 can promote
tumour progression, angiogenesis, inhibit apoptosis, and it is
associated with poor survival. TIMP-2 is primarily known for its
inhibitory activity on MMP-2, but it also has MMP-independent
activities. In the current study, TIMP-1 and -2 were degraded by
Td-CTLP to inactive forms. Thus, by acting on TIMPs, Td-CTLP
could exert effect on MMP activity and inhibit MMP-independent
activities of TIMPs within the tumour site contributing
carcinogenesis.
In our study, we examined two other inflammation related
factors, acute phase protein a-1-AC and complement component
C1q. Td-CTLP degraded both proteins. Expression of a-1-AC has
been reported in pancreatic and gastric cancers (Allgayer et al,





Figure 1. The presence of Td-CTLP in orodigestive tumour tissues. Immunohistochemical stainings of the Td-CTLP in tongue (A), tonsillar (B),
oesophageal (C), gastric (D), pancreatic (E), and colon cancer (F) tissues. Number of positive tissue samples per total sample size for each tumour
type shown. 3-amino-9-ethylcarbazole (AEC) was used as chromogen (red). All red-stained areas on each tissue section indicate specific detection
of Td-CTLP. Scale bar is 100mm, relevant for all panels.
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present in GI cancers and that locally synthesised C1q can promote
cancer cell adhesion, migration, and proliferation in vivo (Bulla
et al, 2016).
The strength of the study is the use of a highly specific
polyclonal antibody against Td-CTLP. In vivo localisation of the
enzyme in various orodigestive tumours provide a potential insight
into its biological effects. The lack of functional analysis of CTLP in
tumours is a limitation of the study. In addition, the proteins
investigated in vitro were not stained alongside CTLP in tumour
sites, but as discussed here plentiful of reports highlight their
presence and role within orodigestive tumours. The enzyme–
substrate ratios used in vitro were based on our previous studies
with microbial proteases and MMPs, and should not be regarded to
be physiologically or pathologically relevant (Uitto et al, 1988;
Sorsa et al, 1992). There are no data available regarding the level of
such microbial proteases in human body fluids and tissues, and
therefore these ratios are practically impossible to estimate. These
data thus represent a potential existence of such microbial–
protease–MMP tissue destructive cascade.
Our data open a new perspective into the possible role of
periodontal pathogens as aetiologic factors in orodigestive
carcinogenesis. Pathogenic oral bacteria may indeed be translo-
cated into the GI tumours and modulate their growth. Further
studies are warranted to provide deeper understanding about the
mechanisms of Td and its virulence factor CTLP in carcinogenesis.
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Figure 2. SDS–PAGE of fragmentation of pro MMP-8 and -9 and TIMP-
1 and -2 by Td-CTLP. (A) Lane 1: proMMP-8 incubated with buffer; lane
2: proMMP-8þAPMA (organomercurial MMP-8 activator) indicates that
proMMP-8 was completely activated by APMA after 60 min; lanes 3–5:
Td-CTLP activated proMMP-8 during 20, 40, and 60 min incubations.
(B) Lane 1: proMMP-9 incubated with buffer; lane 2: proMMP-
9þAPMA (organomercurial MMP-8 activator) indicates that proMMP-9
was completely activated by APMA after 60 min; lanes 3–5: Td-CTLP
activated proMMP-9 during 20, 40, and 60 min incubations. (C) Lane 1:
TIMP-1 incubated with buffer; lanes 2 and 3: TIMP-1 incubated with
Td-CTLP indicates that TIMP-1 was degraded to smaller fragments after
60 min. (D) Lane 1: TIMP-2 incubated with buffer; lanes 2–4: TIMP-2
incubated with Td-CTLP indicates that TIMP-2 was degraded to smaller
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Figure 3. Western immunoblot analysis of conversion of pro MMP-8
and -9 by Td-CTLP. (A) Lane 1: pro MMP-8 incubated with buffer; lane
2: pro MMP-8 incubated with tumour-associated trypsin-2; lanes 3–5:
pro MMP-8 incubated with Td-CTLP for 20, 40, and 60 min. (B) Lane 1:
pro MMP-9 incubated with buffer; lane 2: pro MMP-9 incubated with
tumour-associated trypsin-2; lanes 3–5: pro MMP-9 incubated with Td-
CTLP for 20, 40, and 60 min, respectively. Treponema denticola-CTLP
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Figure 4. SDS–PAGE of fragmentation of immunomodulatory proteins
by Td-CTLP. (A) Lane 1: a-1-AC incubated with buffer; lanes 2 and 3:
a-1-AC incubated with Td-CTLP indicated that Td-CTLP completely
degraded a-1-AC in 30 and 60 min. (B) Lane 1: C1q incubated with
buffer; lanes 2 and 3: C1q incubated with Td-CTLP indicated that
Td-CTLP degraded C1q in 30 and 60 min incubations.
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Thomas G, Ylipalosaari M, Strö M PÅ, Lopez-Otin C, Sorsa T, Kantola S,
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Figure 5. (A) SDS–PAGE (10%; Coomassie Brilliant Blue staining)
analysis of the effects of Td-CTLP on native soluble type I and II
collagen degradation by MMP-8. Lane 1: 1.5mM type I collagen; lane 2:
type I collagen incubated with pro MMP-8; lane 3: type I collagen
incubated with Td-CTLP-treated MMP-8; lane 4: type I collagen
incubated with Td-CTLP; lane 5: type II collagen; lane 6: type II
collagen incubated with MMP-8; lane 7: type II collagen incubated with
Td-CTLP. a1, a2, and b1 indicate intact soluble native type I and II
collagen monomers and dimers and bA and aA indicate their
characteristic 34-cleavage products resulting from collagenase activity.
(B) Type I gelatin-zymographic analysis of the effects of Td-CTLP on
human 92 kDa proMMP-9. Gelatinolytic 80–95 kDa Td-CTLP (lane 1)
converts time-dependently (0–60 min) 92 kDa pro MMP-9 (lane 2) to
82 kDa gelatinolytically active form of MMP-9 (lanes 3–5, indicated by
an arrow).
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